amikacin has been researched along with mannitol in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bilton, D | 1 |
| Brown, MN; Haggard, WO; Harrison, ZL; Jennings, JA; Pace, LR | 1 |
1 review(s) available for amikacin and mannitol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for amikacin and mannitol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
What did we learn from the North American Cystic Fibrosis Conference?
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Chloride Channels; Clinical Trials as Topic; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Diuretics, Osmotic; Genetic Therapy; Humans; Ion Transport; Mannitol; Quality of Health Care; Saline Solution, Hypertonic; United States | 2008 |
Characterization and Antibiofilm Activity of Mannitol-Chitosan-Blended Paste for Local Antibiotic Delivery System.
Topics: Amikacin; Anti-Bacterial Agents; Biofilms; Chitosan; Drug Carriers; Drug Delivery Systems; Inflammation; Mannitol; Microbial Sensitivity Tests; Polyethylene Glycols; Staphylococcus aureus; Vancomycin | 2019 |